J. Stern & Co’s Eli Lilly LLY Stock Holding History

J. Stern & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.77M	Buy	4,814 +295	+7%	+$301K	0.55%	21
2026 Q1	$4.16M	Buy	4,519 +753	+20%	+$763K	0.4%	22
2025 Q4	$4.05M	Sell	3,766 -4,977	-57%	-$4.76M	0.34%	22
2025 Q3	$6.67M	Buy	8,743 +4,542	+108%	+$3.38M	0.5%	29
2025 Q2	$3M	Buy	4,201 +152	+4%	+$118K	0.26%	27
2025 Q1	$3.34M	Buy	4,049 +564	+16%	+$469K	0.32%	25
2024 Q4	$2.69M	Buy	3,485 +673	+24%	+$557K	0.25%	25
2024 Q3	$2.49M	Buy	2,812 +902	+47%	+$811K	0.27%	22
2024 Q2	$1.73M	Buy	+1,910	New	+$1.53M	0.21%	24
2024 Q1	–	Sell	-554	Closed	-$358K	–	42
2023 Q4	$358K	Buy	+554	New	+$323K	0.07%	26

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Stern & Co's LLY Position: Q2 2026 in Review

J. Stern & Co increased its Eli Lilly (LLY) stake by 6.5% in Q2 2026, buying an estimated $301K and bringing the position to 4,814 shares worth $5.77M. The position accounts for 0.55% of the portfolio, ranked #21.

J. Stern & Co first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.67M in Q3 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

J. Stern & Co held 4,814 shares of Eli Lilly worth $5.77M as of Q2 2026.
J. Stern & Co bought 295 Eli Lilly shares in Q2 2026, an estimated $301K.
Eli Lilly made up 0.55% of J. Stern & Co's portfolio in Q2 2026, its #21 holding.
J. Stern & Co first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
J. Stern & Co's Eli Lilly position peaked at $6.67M in Q3 2025.
4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on J. Stern & Co's 13F filing for Q2 2026, filed 14 Aug 2026.